Ajay Goel

Ajay Goel, Ph.D., AGAF, is a Professor and Chair at the City of Hope in the Department of Molecular Diagnostics and Experimental Therapeutics, where he also founded the Biotech Innovations program. His work focuses on gastrointestinal cancer detection and treatment, particularly through epigenetics, circulating biomarkers, and precision oncology. With over 300 publications and 30 patents, he has held leadership roles at Baylor Scott & White Research Institute and Curtin University.

• Education:
  • Ph.D. in Biophysics, Panjab University (1996)
  • M.S. (Honors), Biophysics, Panjab University (1990)
  • B.S. (Honors), Biophysics, Panjab University (1988)

Research Interests span cancer genomics, non-invasive diagnostics, and epigenetic therapies. He is pioneering blood tests for early detection of colon, pancreatic, and ovarian cancers, aiming to integrate them into annual health exams. His work bridges genomic technologies with traditional medicine, exploring Ayurvedic compounds like turmeric for preventive strategies.

Scientific Contributions include:

• Over 300 peer-reviewed articles
• 30+ international patents in genomics
• Leadership in the American Gastroenterology Association
• 2023 AACR-Lustgarten Award
• 2022 Distinguished National Alum Award
• 2020 Erudite Scholar Recognition

At City of Hope, Goel directs the Goel Lab, which develops circRNA and DNA methylation biomarkers for cancer diagnostics. His collaborations with institutions like the Pancreatic Cancer Detection Consortium and Early Detection Research Network highlight his role in advancing multi-omics approaches to cancer care.